There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

DOI:: 10.23736/s1121-421x.20.02771-3

PubMed ID:: 32397695

Data availability:

Comments

Comment on this article

scite_

Cited by 5

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Authors: Francesco Di Pierro, Somia Iqtadar, Amjad Khan …
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Authors: Francesco Di Pierro, Giuseppe Derosa, Pamela Maffioli …
COVID-19 and cellular senescence
Authors: Clemens Schmitt, Tamar Tchkonia, Laura Niedernhofer …

See all cited by

Quercetin phytosome® as a potential candidate for managing COVID-19

Read this article at